Who can use Evista(Raloxifene)?

This section describes the medical conditions for which EVISTA is approved.

Approved Uses

EVISTA is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Additionally, it is approved for the reduction of risk of invasive breast cancer in postmenopausal women, which includes women diagnosed with osteoporosis and those identified as being at high risk for invasive breast cancer. It is crucial to note that this medication is not indicated for the treatment of existing invasive breast cancer, reduction of recurrence risk, or reduction of noninvasive breast cancer risk.